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Abstract
OBJECTIVE: To assess the effectiveness of violate
oil from Blumea Balsamifera (L.) DC. leaves (BB oil)
on wound healing in mice.
METHODS: Undiluted BB oil and its diluted solu-
tions with olive oil to 1/5 and 1/10 to yield BB oil1/5
and BB oil1/10 were applied to the wounded skin be-
fore wound healing conditions were assessed by
healing rate, histopathology, and contents of colla-
gen, hydroxyproline, and Neuropeptide Substance
P (SP). All above results were compared with the ef-
ficacies of the control, pure olive oil, basic fibro-
blast growth factor (BFGF), and cream of Jing Wan
Hong (JWH).
RESULTS: BB oil1/5 and BB oil1/10 improved wound
contraction and closure. Histopathology study fur-
ther confirmed a desirable histological organiza-
tion of wound tissues. BB oil1/5 and BB oil1/10 reduced
the number of inflammatory cells, increased
wound-healing rates, and significantly increased
the hydroxyproline content. Both BB oil1/5 and BB
oil1/10 improved formation of collagen, and reduced
the frequency of fibroblasts. Moreover, BB oil1/5 and
BB oil1/10 markedly promoted SP expression. Howev-
er, undiluted BB oil may induce skin thickening and
hardening, inhibite collagen synthesis and delay
complete skin wound healing.
CONCLUSION: The BB oil1/5 and BB oil1/10 promoted
capillary regeneration, blood circulation, collagen
deposition, granular tissue formation, epithelial de-
position, and wound contraction. The mechanism
underlying the action might be related to induc-
tion of SP secretion, and the proliferation and differ-
entiation of mesenchymal cells.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Traditional medicine practitioners have described the
therapeutic efficacies of many traditional and indige-
nous plants against diseases.1 Natural products that are
safe, and possess physiological properties are excellent
sources of new therapeutics for the treatment of condi-
tions like mechanical damage of the skin.2,3 Some re-
searchers therefore have shifted their focus to the po-
tential wound healing properties of plants.4
Wound healing is a process of restoring damaged cells
and tissues.5-7 The phases of wound healing occur in a
precise and regulated order. Firstly, it involves hemosta-
sis and inflammation; secondly, mesenchymal cells dif-
ferentiate, proliferate, and migrate to the wound site;
thirdly, angiogenesis and epithelial deposition at the
wound surface site. Finally, synthesis, cross-linking and
alignment of collagen is required to provides structural
strength to the wound healing tissue.8 The wound also
undergoes physical contraction, which might be medi-
ated by contractile fibroblasts.9 Neuropeptide Sub-
stance P (SP) is a pro-inflammatory neuropeptide, and
modulates inflammatory responses of skin wounds. SP
also promotes the synthesis and metabolism of fibro-
blast and increases accumulation of collagen in the pro-
liferative phase of mesenchymal cell growth and dy-
namics.10 In addition, SP is an important medium in
the process of wound repair and scar healing.11,12
Ainaxiang (Herba Blumeae Balsamiferae), also named
Sambong in some tropical countries, is an herb with a
rich constitution of essential oils that are used in Tradi-
tional Chinese Medicine (TCM).13 In China, Blumea
Balsamifera (L.) DC. normally grows in Hainan and
Guizhou.14,15 Its leaves have been used for healing many
conditions including eczema, dermatitis, skin injury,
skin bruises, beriberi, lumbago, menorrhagia, rheuma-
tism, and some other diseases.16 Recently, the extracts
of the leaves have been verified to display physiological
activities on plasmin-inhibitory,17,18 anti-fungal,19,20 free
radical scavenging and anti-obesity functions.21,22 The
Records of Seeking Herbal Medicines in Lingnan, an
ancient Chinese medical work, described that the ex-
tract from Ainaxiang (Herba Blumeae Balsamiferae),
was used to treat snakebite injury, and skin wounds
and itch. It documented that external application of
the mashed fresh leaves or leaf water washings decoc-
tion could treat traumatic injury, carbuncle and skin
pruritus.23
The main active ingredient in the violate oil from
Blumea Balsamifera (L.) DC. leaves (BB oil) is l-borne-
ol. However, little systematic study has been found on
the pharmacologic use of BB oil. Herein, we have eval-
uated the potential for, and possible mechanisms of ac-
tion of, BB oil to promote wound healing.
METERIALS ANDMETHODS
PLant and its volatile oil preparation
Blumea Balsamifera (L.) DC. was obtained from Luo-
dian, Guizhou, China. It was identified by Dr. Yuxin
Pang, associate researcher fellow at the Tropical Crops
Genetic Resources Institute, Chinese Academy of
Tropical Agricultural Sciences, Danzhou, Hainan, Chi-
na. The herbarium voucher specimen (TCGRI 10011)
was saved. BB oil was obtained by distilling its
air-dried leaves with steam at Guizhou Ai-Yuan Ecolog-
ical Medicine Development Industry, Guizhou, China.
A yield of 0.1 mL of BB oil was obtained from each Kg
of fresh Blumea Balsamifera (L.) DC. leaves.
Determination of l-borneol content in BB oil
The standard l-borneol (98% , Batch No. 10147015)
was produced by Alfa Aesar, Heysham, Lancs, UK.
The content of l-borneol of BB oil was determined by
gas chromatography (GC, Agilent 7890, Santa Clara,
CA, USA), using ethyl acetate as the solvent. The sepa-
ration was performed on a HP-5 quartz capillary col-
umn (30 m×320 μm, 0.5 μm) equipped with a flame
ionization detector (FID) detector. The injection vol-
ume was 0.6 μL and was carried out by nitrogen with-
out splitting. The injector temperature was maintained
at 250℃ and detector, 280℃ . The oven temperature
was programmed from 60℃ for 1 min, raised to 100℃
at a rate of 5℃/min, and to 260℃ at a rate of 20℃/
min, and isotherm at 260℃ for 5 min. The number of
theoretical plates was more than 50 000 and the separa-
tion degree was greater than 1.5. The external standard
method was used.
Animals
Ninety eight healthy Kun-Ming mice of specific patho-
gen-free (SPF) grade (No. SPF2012005) weighing (19±
1) g were supplied by the Experimental Animal Center
of Guangzhou University of Chinese Medicine [Certifi-
cate of quality No. SCXK (Yue) 2008-0020], Guang-
zhou, China. Forty nine female and forty nine male
mice were maintained under 20℃-25℃ with a relative
humidity of 40%-70% and normal photo periods (12 h
light/12 h dark). The mice were individually housed
and fed a normal diet and allowed access to water ad li-
bitum in the Laboratory of Tropical Medicinal Plants
Resources, Tropical Crops Genetic Resources Institute,
Chinese Academy of Tropical Agricultural Sciences,
Danzhou, China. This study was registered at and au-
thorized by Guangdong Pharmaceutical University,
Guangzhou, China and Tropical Crops Genetic Re-
sources Institute, Chinese Academy of Tropical Agri-
cultural Sciences, Danzhou, China (Trial registration:
current controlled trials: GDPU 2012005). The experi-
ment was conducted in accordance with the UK Ani-
mal Care and Control Act of 1986, and the National
Institutes of Health guide for the care and use of labo-
ratory animals.
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Animal modeling and grouping
Totally 98 mice were randomly divided into seven
groups by random number table method: Control (n=
14), solvent control (n=14), basic fibroblast growth fac-
tor (BFGF) (n=14), cream of Jing Wan Hong (JWH)
(n=14), undiluted violate oil from Ainaxiang leaves
(Blumeae Balsamiferae Folium) (BB oil) (n=14), BB
oil diluted in olive oil to v/v=1/5 (BB oil1/5) (n=14),
and BB oil diluted in olive oil to v/v=1/10 (BB oil1/10)
(n=14).
Mouse wound model and drug treatments
Mice were anesthetized in advance by intraperitoneal
injection with 5% chloral hydrate (0.1 mL per 10 g).
The model skin was depilated with electric clippers.
The part of each mouse that was at the back of the
front leg, and located along the spine on the right side
of the mouse at a distance of 1.0 cm, was perforated
with a sterilized puncher. The diameter of the wound
was 1.5 cm. Then the wound was trimmed with a scal-
pel to the depth of the fascia. Hemostasis was carried
out with a piece of sterile gauze. By doing these, the
mechanically induced wound animal model was
formed.26
Approximately 0.05 mL of the different drug prepara-
tions was applied to the wound once daily. Three
groups, undiluted BB oil, BB oil1/5 and BB oil1/10, were
set up respectively. The BB oil1/5 and BB oil1/10 were BB
oil diluted in olive oil to 1/5 and 1/10 (v/v), respective-
ly. There was no drug treatment in the control group,
and 0.05 mL olive oil (Shanghai Lingfeng Chemical
Reagent Co., Ltd., Shanghai, China, 20120816) was
applied in the solvent control group. There were two
positive groups. A prepared solution of BFGF (basic fi-
broblast growth factor, Zhuhai Essex Bio-Pharmaceuti-
cal Co., Ltd., Zhuhai, Guangdong, China, No.
S10980077) was applied in the BFGF group. The
cream of JWH (Jingwanhong, Tianjin Darentang Jing-
wanhong Pharmaceutical Co., Ltd., Tianjin, China,
No. Z12020440) was applied in the JWH group.
Observation of wound healing
The number and relative production of the exudates,
contraction, and the scab and skin colors of the wound
were observed on days 1, 3, 5, 7 and 10 following treat-
ments.
Wound healing rate determination
On days 1, 3, 5, 7, and 10, the wound healing rate
(WHR) was measured by weighs. The wound was cov-
ered with transparent film and labeled along the
wound edge. Then, the required area was cut off and
weighed. The wound healing process was considered to
be completed once the WHR reach 95%.27
WHR (%)=[(Wo－Wu)/Wo]×100
Wo: Original wound area weight; Wu: Unhealed wound area
weight.
Histopathological observation
On days 3, 7 and 10, the skin specimens of the wound
were cut out and immediately fixed in 10% v/v neu-
tral- formaldehyde for 24 h. The specimens were em-
bedded in paraffin and 4 μm sections were sliced for
hematoxylin and eosin (HE) staining (HE staining kit,
Nanjing Jiancheng Bioengineering Institute, Nanjing,
China, batch No. 20120926). The slices were observed
under a microscope for histological evaluation of fibro-
blast proliferation, angiogenesis, epithelial regenera-
tion, and collagen deposition.
Determination of collagen
On days 3, 7 and 10, the skin specimens were stained
by using the Masson staining kit (Nanjing Jiancheng
Bioengineering Institute, Nanjing, China, batch No.
20121119) to determine the content of collagen. Ten
random views of each slice were observed under micro-
scope (×40). Then the optical density (OD) and area
of each view were assessed by using the software Image-
Pro plus 6 to determinate collagen deposition.
Determination of hydroxyproline
On days 3, 7 and 10, the basal skin tissues were cut
from the center of the wounds. The determination of
hydroxyproline was carried out according to the hy-
droxyproline alkali hydrolysis kit (Nanjing Jiancheng
Bioengineering Institute, Nanjing, China, batch No.
20121023).
Determination of SP
SP content in the wound was determined by using the
SABC (Streptavidin-Biotin Complex kit, Wuhan
Boster Bioengineering Co., Ltd., Wuhan, China, batch
No. 07J16BM). Five random views of each slice were
observed under microscopy (× 40). The OD of each
view was assessed by using the software program Image-
Pro plus 6 to determinate SP content.
Statistical analysis
Results were expressed as mean ± standard deviation
(SD) and statistical analysis was performed by using
Duncan's New Multiple Range Test. Data analysis was
performed by using the software SPSS 21 (SPSS Inc.,
Chicago, IL, USA). The statistical significance was set
at P<0.05.
RESULTS
Content of l-borneol
The GC maps of the standard and samples are shown
in Figure 1. L-borneol showed a good linear relation-
ship under 0.05-0.78 mg/mL. The regression equation
was Y=13012X-61.963, with an average recovery of
100.4% and a relative standard deviation (RSD) of
0.93% . The content of l-borneol in BB oil in this
study was 22.7%.
Situation of wound healing
All mice grew well and their weights increased steadily.
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No unusual drinking or urination was observed. The
wound tissues in BFGF, JWH, BB oil1/10 and BB oil1/5
groups were ruddy, and arranged in order and no skin
scrapings on the edge. On day 2, the new epidermis
covered the wound edge, and the inflammatory re-
sponse yet undetected. Then, the wound of the control
mice and solvent control groups were rather black and
dry. On day 3, wound edges of some mice were epithe-
lized. However, in the undiluted BB oil groups, the
wounded skin was dark and some wounds dehiscence
and hemorrhage were observed. After the wound
healed, the skin was partially thickened and hardened.
Some mice in undiluted BB oil group depilated in a
large area, and the depilated skin was dark red.
Wound healing rate
By day 3, the BB oil1/5 and BB oil1/10 groups showed sig-
nificant high WHRs than control (P<0.05). On days 5
and 7, these two groups healed the wounds significant-
ly. The wounds in the BB oil1/5 and BB oil1/10 groups
had achieved more than 60.0% wound contraction.
However, the WHR in the undiluted BB oil group
were low by day 10 (Table 1).
Histopathological evaluation
On day 3, inflammatory cells had infiltrated the
wound, and a few capillaries had formed. The infiltra-
tion with inflammatory cells were light, and new capil-
laries and fibroblast were significantly more evident fol-
lowing treatments with BFGF, JWH, BB oil1/5 and BB
oil1/10 as compared the other treatments. The collagen
depositions in these four groups were better. The epi-
dermis in the undiluted BB oil group showed signifi-
cant thickening, and the fibroblasts were smaller and
in a disordered state. The wounds in this group healed
much worse than did the other groups (Figure 2).
Effects on content of collagen
We evaluated the collagen contents, fibrous proteins
and constituent of non-contractile connective tissues,
Group
Control
Solvent control
BFGF
JWH
BB oil
BB oil1/5
BB oil1/10
Day 3 (n=14)
32.4±5.0
27.3±9.1
37.4±6.3a,b
36.8±8.7b
30.2±7.4
35.1±9.6c
34.3±7.6c
Day 5 (n=14)
52.4±9.0
57.1±8.5
60.1±6.9a
60.6±8.3a
46.0±10.2b
64.3±8.5d,c
62.2±9.1a
Day 7 (n=14)
78.8±6.5
82.9±4.5
85.8±5.6d
84.5±5.1d
72.0±7.3a,b
90.3±7.2d,b
83.5±5.5a
Day 10 (n=10)
97.1±2.5
96.4±3.2
97.9±1.2
98.5±0.4
97.5±0.5
98.6±0.7c
98.0±0.4
Table 1 Effect of BB oil on wound healing rate (%)
Notes: control: no drug treatment; solvent control: olive oil; BFGF: basic fibroblast growth factor; JWH: the cream of Jingwanhong; BB
oil: undiluted violate oil of Blumea Balsamifera (L.) DC. leaves; BB oil1/5: BB oil diluted in olive oil to v/v=1/5; BB oil1/10: BB oil diluted in
olive oil to v/v=1/10. Approximately 0.05 mL of each drug preparation was applied once a day to the wound of rats in each group respec-
tively except the control group. Compared with control group, aP<0.05, dP<0.01; compared with solvent control group, cP<0.05, bP<0.01.
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Figure 1 Gas chromatogrammaps of the standard and samples
A: standard substance; B: violate oil of Blumea Balsamifera (L.) DC. leaves (BB oil) samples for determination of l-borne-
ol (arrow).
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by surveying the OD of the stained blue slide of the
wound.28 On day 3, there were few collagen fibers in
the proliferating granulation tissue. The average OD in
the BB oil1/5 and BB1/10 groups were 0.303 and 0.322,
which were higher than other groups (P<0.01, Table
2).
Effects on hydroxyproline content
On day 3, there were statistically significant differences
in hydroxyproline content of each treatment group as
compared with the control and solvent treatment
groups (P<0.01). The contents of hydroxyproline in
undiluted BB oil, BB oil1/5 and BB oil1/10 groups were
1.64, 2.00 and 2.30 μg/mL respectively, which were
markedly higher than that seen in the control groups
with 59.22%, 94.18% and 123.30%, and were 1.76,
2.15, 2.47 times than that seen in the solvent control
group. However, on day 10, the hydroxyproline con-
tent in BB oil group (2.87 μg/mL) was the lowest (Ta-
ble 3).
Effect on the content of SP
SP shows the most positive reaction appearing on slice
specimens as a yellow-brown coloration. The cells in
the negative control group were stained blue without a
positive reaction. The average OD represents the con-
tent of SP (Table 4). On day 3, the average OD of SP
in the BB oil group was 0.0212, which was higher than
was seen for the other groups, especially in the context
of the control and solvent control groups (P<0.01). On
day 7, SP in the undiluted BB oil and BB oil1/5 groups
increased highly significantly as compared with that
seen in the control and solvent control groups (P<
0.01).
DISCUSSION
In the present study, the effect of BB oil was investigat-
ed. The major active ingredient of BB oil, l-borneol, in-
duces resuscitation, relieves pain, has an anti-inflamma-
tory effect, activates blood, and inhibits sympathetic
nerve conduction. 24, 25, 30 Our findings revealed that BB
oil1/5 and BB oil1/10 improved wound contraction and
closure, and the effects were extremely and distinctly
strong. Histopathological evaluation of the wound pro-
vided additional evidence of a more desirable histologi-
cal organization. Our results revealed that, with the
concentrations tested in the study, BB oil improved
the formation of collagen and fibroblasts, and reduced
the number of inflammatory cells that were required to
accelerate effective wound healing and granulation of
Group
Control
Solvent control
BFGF
JWH
BB oil
BB oil1/5
BB oil1/10
Day 3
0.128±0.056
0.155±0.094
0.210±0.081a
0.192±0.044a
0.190±0.048a
0.303±0.049b,c
0.322±0.044b,c
Day 7
0.327±0.027
0.299±0.106
0.309±0.065
0.524±0.078b,c
0.304±0.055
0.430±0.034b,c
0.423±0.060b,c
Day 10
0.467±0.086
0.452±0.080
0.464±0.064
0.599±0.026b,c
0.459±0.030
0.562±0.068b,c
0.546±0.040b,c
Table 2 Effect of BB oil on collagen content ( xˉ ±s)
Notes: control: no drug treatment; solvent control: olive oil; BFGF: basic fibroblast growth factor; JWH: the cream of Jingwanhong; BB
oil: undiluted violate oil of Blumea Balsamifera (L.) DC. leaves; BB oil1/5: BB oil diluted in olive oil to v/v=1/5; BB oil1/10: BB oil diluted in
olive oil to v/v=1/10. Approximately 0.05 mL of each drug preparation was applied once a day to the wound of rats in each group respec-
tively except the control group. Compared withcontrol group, aP<0.05, bP<0.01; compared with solvent control group, cP<0.01.
Group
Control
Solvent control
BFGF
JWH
BB oil
BB oil1/5
BB oil1/10
Day 3
1.03±0.36
0.93±0.30
1.42±0.33a,c
1.85±0.47b,c
1.64±0.38b,c
2.00±0.32b,c
2.30±0.73b,c
Day 7
1.87±0.61
1.54±0.31
1.95±0.40d
1.89±0.40d
2.33±0.77c
2.11±0.34c
2.05±0.38c
Day 10
3.91±1.09
3.43±0.27
3.96±0.57d
4.02±0.71d
2.87±0.72a,d
3.91±0.61d
4.13±0.89d
Table 3 Effect of BB oil on hydroxyproline content (μg/mL, xˉ ±s)
Notes: control: no drug treatment; solvent control: olive oil; BFGF: basic fibroblast growth factor; JWH: the cream of Jingwanhong; BB
oil: undiluted violate oil of Blumea Balsamifera (L.) DC. leaves; BB oil1/5: BB oil diluted in olive oil to v/v=1/5; BB oil1/10: BB oil diluted in
olive oil to v/v=1/10. Approximately 0.05 mL of each drug preparation was applied once a day to the wound of rats in each group respec-
tively except the control group. Compared withcontrol group, aP<0.05, bP<0.01; compared with solvent control group, cP<0.01, dP<0.05.
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new tissue in the proliferative phase.
The healing process depends on the biosynthesis and
deposition of collagens and their maturation. Filling of
the wound with granulation tissue serves to heal the
B1A1 C1 D1
E1 F1 G1
B2A2 C2 D2
E2 F2 G2
B3A3 C3 D3
E3 F3 G3
Figure 2 Effect of different treatments on histopathological changes (HE, ×40)
A1-G1: the expressions on day 3; A2-G2: the expressions on day 7; A3-G3: the expressions on day 10. A1, A2 and A3: the expres-
sion of control (with no drug treatment); B1, B2 and B3: the expression of solvent control (olive oil treated); C1, C2 and C3: the ex-
pression of BFGF (basic fibroblast growth factor treated); D1, D2 and D3: the expression of JWH (the cream of Jing Wan Hong
treated); E1, E2 and E3: the expression of BB oil [undiluted violate oil of Blumea Balsamifera (L.) DC]; F1, F2 and F3: the expression
of BB oil1/5 (BB oil diluted with olive oil, v/v=1/4,); and G1, G2 and G3: the expression of BB oil1/10 (BB oil diluted with olive oil, v/v=1/
9). HE: hematoxylin-eosin.
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wound. The granulation tissue is comprised of fibro-
blasts, collagen, edematous fluids, and small neovascu-
larized blood vessels. The increase in granular tissue
dry weight suggests an increase in proteins. Thus, the
healing process depends predominantly on the subse-
quent maturation of collagen.31,32 Collagen is com-
prised of amino acids (e.g., hydroxyproline), and it is
an important component of strengthening and support-
ing extracellular tissues. Breakdown of collagen liber-
ates free hydroxyproline and peptides.26,4,33 Therefore,
the content of hydroxyproline is an index of collagen
turnover.34
In this study, BB oil1/5 and BB oil1/10 demonstrated a sig-
nificant increase in the hydroxyproline content of the
granulated tissue, indicating an increase of collagen
turnover. Both these two diluted BB oils stimulated
wound healing more potently and more effectively
than did the others. These findings implied that BB
oil1/5 and BB oil1/10 promoted wound healing by influ-
encing the proliferative and remodeling phases of
wound healing, and do so via the pathways of angio-
genesis, collagen deposition, granular tissue formation,
epithelial deposition, and wound contraction. This re-
sult was also relevant in the context of other traditional
medicinal plants. Topical applications of many tradi-
tional medicinal plants for skin wounds have been
proved to have certain positive effects. These findings
made these folk herbs potential skin wound healing
agents.29,35,36
Peripheral nerves that conduct wounded tissues, also re-
lease SP, and then SP participates in the regulation of
wound healing. SP plays an important role in communi-
cating the nervous system with the wounded tissues.37,38
In this experiment, determination of SP content
showed that BB oil, BB oil1/5 and BB oil1/10 markedly
promoted the expression of SP in the proliferative
phase. The wound healing mechanism, under condi-
tions of optimized concentrations of BB oil might be
mediated, at least in part, by an increase in SP secre-
tion. In addition, BB oil1/5 and BB oil1/10 increased the
formation of new blood capillaries in the proliferative
phase. This result could verify the efficacy of BB oil of
its claimed Chinese medical efficacy "it can improve
blood circulation and eliminate extravasated blood,"
and this efficacy might be associated with SP secretion.
Moreover, the effect of BB oil1/5 and BB oil1/10 on capil-
lary regeneration, blood circulation and accelerated
wound healing might also be due to SP secretion. Possi-
ble mechanisms contributing to wound healing might
be associated with SP secretion and the proliferation
and differentiation of regulated cells.
However, the results in the undiluted BB oil group sug-
gest that undiluted BB oil was not an optimum solu-
tion for accelerating wound healing. It should be dilut-
ed before being used to heal wounds. Further research
and critical analysis on this filed is needed.
In summary, BB oil1/5 and BB oil1/10 promoted capillary
regeneration, blood circulation, collagen deposition,
granular tissue formation, epithelial deposition, and
wound contraction. The BB oil1/5 and BB oil1/10 tested
in this study can promote and enhance wound healing.
These results may provide significant evidence for BB
oil in clinical practice.
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